These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10976543)

  • 1. Plasma concentrations of active simvastatin acid are increased by gemfibrozil.
    Backman JT; Kyrklund C; Kivistö KT; Wang JS; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Aug; 68(2):122-9. PubMed ID: 10976543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
    Schneck DW; Birmingham BK; Zalikowski JA; Mitchell PD; Wang Y; Martin PD; Lasseter KC; Brown CD; Windass AS; Raza A
    Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
    Backman JT; Kyrklund C; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2002 Dec; 72(6):685-91. PubMed ID: 12496749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Backman JT; Luurila H; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.
    Kyrklund C; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Jun; 73(6):538-44. PubMed ID: 12811363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ; Jalava KM
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast.
    Karonen T; Filppula A; Laitila J; Niemi M; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2010 Aug; 88(2):223-30. PubMed ID: 20592724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo.
    Tornio A; Niemi M; Neuvonen M; Laitila J; Kalliokoski A; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2008 Sep; 84(3):403-11. PubMed ID: 18388877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone.
    Tornio A; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2006 Aug; 62(8):645-51. PubMed ID: 16832679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
    Niemi M; Kajosaari LI; Neuvonen M; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):441-7. PubMed ID: 15025742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara G; Reynolds CV; Pommier F; Humbert H; Yeh C; Prasad P
    Curr Med Res Opin; 2007 Mar; 23(3):631-40. PubMed ID: 17355744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
    Bergman AJ; Murphy G; Burke J; Zhao JJ; Valesky R; Liu L; Lasseter KC; He W; Prueksaritanont T; Qiu Y; Hartford A; Vega JM; Paolini JF
    J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.